Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KDS2010 in Overweight or Obese Patients
NCT07009171Phase 2Recruiting
- Sponsor
- NeuroBiogen
- Start
- Jul 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tisolagiline in obesity, sponsored by NeuroBiogen. Started Jul 2025; status: recruiting.
02
Drugs
tisolagiline
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07009171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07009171.